FDA Approvals - FDA Approves Genzyme's Myozyme(R) for All Patients with Pompe Disease
FDA Approves Genzyme's Myozyme(R) for All Patients with Pompe Disease (PR Newswire via Yahoo! Finance)
Genzyme Corp. announced today that the Food and Drug Administration has granted marketing approval for Myozyme in the United States.
Kensey Nash Receives FDA 510(k) Clearance for New ThromCat(TM) Thrombectomy Catheter System (PR Newswire via Yahoo! Finance)
Kensey Nash Corporation today announced that it has received 510 clearance for its ThromCat Thrombectomy Catheter System from the U.S. Food and Drug Administration .
Study assesses relationship between conflicts of interest and voting patterns at FDA meetings (EurekAlert!)
Disclosures of conflicts of interest at Food and Drug Administration (FDA) drug advisory committee meetings are common, often of considerable financial value, and rarely result in the recusal of advisory committee members, but excluding those with conflicts would not have altered the overall vote outcome at any meeting, according to a study published in the April 26 issue of JAMA.